How a Venture Capital Fund Operates

Leading VCs on Investment Strategies, Fund Management, and Best Practices for Success

Publication Date	April 2006
Publisher	Aspatore
Product Type	Book
Pages	132
ISBN Number	1596222905
Product Code	ASO00176

Price

£53.00
approximately: $99 | €67

PRINT £53 ($99 | €67)

Order above formats by FAX

Summary

Winning Legal Strategies for Food and Drug Companies is an authoritative, insider's perspective on the legal issues companies face in meeting FDA regulations. Featuring department heads, group chairs, and leading partners representing some of the nation's top firms, this book provides a broad, yet comprehensive overview of this highly-regulated practice area. From gaining FDA approval for a product to complying with FDA policies once the product is introduced on the market, these seasoned professionals cover the important aspects of the practice area. The different niches and breadth of perspectives represented these outstanding authors enable readers to get inside some of the great legal minds of today, as experts offer up their thoughts around the keys to success. For understanding and implementing the practices that separate insiders from the rest, Winning Legal Strategies for Food and Drug Companiesis truly an indispensable resource.

Chapters include:

1) James N. Czaban , Shareholder and Chair, FDA Practice Group, Heller Ehrman LLP: "Being Compliant While Standing Your Ground";
2) Carolyne Hathaway, Partner, and John Manthei, Partner: Latham & Watkins- "Stepping in Early and Adding Real Value";
3) Sandra D. Morar, Member, McGrath, North, Mullin & Kratz, "An Overview of What a Food Lawyer Needs to Know";
4) William C. Waller, Corporate Regulatory Counsel, Chiron Corporation, "Drug Law: An In-House Lawyer's Perspective";
5) John A. Gilbert Jr., Director, Hyman, Phelps & McNamara PC: "The Regulation of Controlled Substances";
6) Marsha C. Wertzberger, Member, & Wayne .H. Matelski, Member: Arent Fox - "Increasing the Company's Understanding of How It Is Regulated";
7) Robert B. Nicholas, Partner and Chair, FDA Practice Group, McDermott Will & Emery LLP: "Science, Law, and Politics for FDA-Regulated Companies";
8) Charles R. McConachie, Partner, Simpson Woolley McConachie: "Keys to Success: Being Honest, Educated, and Timely";
9) Frederick A. Stearns, Partner, Keller and Heckman LLP, "Getting Things Right from the Beginning."